You are here: Industry Insights > Asthma

News List

More Studies Link Vaping to Asthma, COPD drugs
January 15, 2020
Lung illnesses and deaths from vaping have been grabbing headlines for months, and now two new studies offer fresh evidence pointing to long-term respiratory concerns.
Kids' 'Microbiome' May Play Key Role in Asthma drugs
December 25, 2019
Microbes that live in a child's upper airway could be linked to severe asthma attacks, new research suggests.For parents, it's an all-too familiar scene: A child's seemingly harmless cough quickly escalates to wheezing, gasping and an urgent need for emer
Novartis Will Not Support Further Development of Fevipiprant for Asthma americanpharmaceuticalreview
December 18, 2019
Novartis announced topline results from its pivotal global Phase III LUSTER-11 and LUSTER-22 studies exploring the efficacy and safety of the investigational oral, once-daily ...
Novartis’ fevipiprant fails to meet clinically relevant threshold in phase III asthma studies pharmaceutical-business-review
December 17, 2019
Novartis announced that its asthma treatment fevipiprant has failed to meet the clinically relevant threshold in Luster phase III studies.
Better Asthma Care in Puskesmas Improves Disease Control and Reduces Economic Burden En-CPhI.CN
October 15, 2019
In line with Indonesia's National Health Coverage (BPJS)'s objective to strengthen government primary healthcare clinics (Puskesmas) ...
CDC: Asthma Visit Rates Decreased From 2001 to 2016 drugs
September 23, 2019
Asthma is a common reason for physician visits, although the rate of asthma visits decreased from 2001 through 2016 ...
Treatment approved for young children with severe eosinophilic asthma europeanpharmaceuticalreview
September 17, 2019
Nucala is the first biologic approved in the US for six- to 11-year-old children with severe eosinophilic asthma by the FDA.
FDA Approves Nucala (mepolizumab) for Six to 11-Year-Old Children with Severe Eosinophilic Asthma drugs
September 16, 2019
GlaxoSmithKline today announced that the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab) for use in children as young as six years old who are living with severe eosinophilic asthma.
As-Needed Inhaler Use an Option for Children With Mild Asthma drugs
August 26, 2019
Children with mild asthma can use inhalers as needed, according to a study published online in the Journal of Allergy and Clinical Immunology: In Practice.
Biomarker may uncover uncontrolled asthma in adults, children: Research expresspharma
August 23, 2019
Cytokine interleukin(IL)-26 could be used as biological marker for uncontrolled asthma in adults, children – could be future goal for new drugs against asthma

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page